
4.40 Delayed Data As of Aug 10 | ![]() Today’s Change | 1.83 Today|||52-Week Range 8.86 | -5.38% Year-to-Date |
The 6 analysts offering 12-month price forecasts for Decibel Therapeutics Inc have a median target of 15.50, with a high estimate of 23.00 and a low estimate of 7.00. The median estimate represents a +252.27% increase from the last price of 4.40.
The current consensus among 6 polled investment analysts is to Buy stock in Decibel Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.